We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Haleon plc (HLN) ORD GBP0.01

Sell:333.00p Buy:333.15p 0 Change: No change
FTSE 100:0.26%
Market closed Prices as at close on 28 March 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Ex-dividend
Sell:333.00p
Buy:333.15p
Change: No change
Market closed Prices as at close on 28 March 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Ex-dividend
Sell:333.00p
Buy:333.15p
Change: No change
Market closed Prices as at close on 28 March 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Ex-dividend
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Haleon plc is a consumer healthcare company. The Company’s product portfolio includes five categories, including oral health, vitamins, minerals, and supplements (VMS), pain relief, respiratory health, digestive health and others. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA and LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company's digestive health and other product offerings also include skin health and smoker’s health. Its oral health brands include Sensodyne, Polident, Parodontax, and Biotene. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, and Flonase. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Fenistil.

Contact details

Address:
Building 5, First Floor, The Heights
BRENTFORD
KT13 0NY
United Kingdom
Telephone:
+44 (01932) 822000
Website:
https://www.haleon.com/

Important dates

Future events
Final dividend payment date 16 May 2024 16/05/24
Trading Announcement 01 May 2024 01/05/24
Past events
Annual report 15 March 2024 15/03/24
Final ex-dividend date 14 March 2024 14/03/24
Final results 29 February 2024 29/02/24
Trading Announcement 02 November 2023 02/11/23
Interim dividend payment date 05 October 2023 05/10/23
Interim ex-dividend date 24 August 2023 24/08/23
Interim results 02 August 2023 02/08/23
Trading Announcement 03 May 2023 03/05/23
Final dividend payment date 27 April 2023 27/04/23
Trading Announcement 20 April 2023 20/04/23
AGM 20 April 2023 20/04/23

General stock information

EPIC:
HLN
ISIN:
GB00BMX86B70
Market cap:
£30.42 billion
Shares in issue:
9.13 billion
Sector:
No specific Industry
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
FTSE 100,FTSE 350,FTSE All Share,FTSE techMARK All Share

Key personnel

  • Brian Mcnamara
    Chief Executive Officer, Executive Director
  • Tobias Hestler
    Chief Financial Officer, Executive Director
  • Keith Choy
    President, Asia Pacific
  • Filippo Lanzi
    President, EMEA and LatAm
  • Lisa Paley
    President, North America
  • Mairead Nayager
    Chief Human Resource Officer
  • Amy Landucci
    Chief Digital and Technology Officer
  • Tamara Rogers
    Chief Marketing Officer
  • Bjarne Tellmann
    General Counsel
  • Bart Derde
    Chief Supply Chain Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.